1. RNA-based therapies: A cog in the wheel of lung cancer defense
   Parvez Khan et al, 2021, Molecular Cancer CrossRef
2. Designing multi-targeted agents: An emerging anticancer drug discovery paradigm
   Rong-geng Fu et al, 2017, European Journal of Medicinal Chemistry CrossRef
3. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
   Luisa M. Bachmann et al, 2023, Molecules CrossRef
4. Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries
   Betul Cicek et al, 2023, Pharmaceuticals CrossRef
5. The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs)
   Rana A. Alaaeddine et al, 2021, Current Medicinal Chemistry CrossRef
6. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition
   Fernán Gómez-Valenzuela et al, 2021, Frontiers in Oncology CrossRef
7. lncRNA FLVCR1‐AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β‐catenin signaling pathway
   Heping Lin et al, 2019, Journal of Cellular Biochemistry CrossRef
8. A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways
   Qing Shi et al, 2017, The AAPS Journal CrossRef